Drug companies give their tax affairs a clean bill of health ahead of Senate grilling

By Heath Aston, Political Correspondent
Updated June 30 2015 - 10:18am, first published 9:41am
Tax Commissioner Chris Jordan said some drug-makers had attempted to "back profits out" of Australia through a combination of transfer pricing and royalty payments to subsidiaries abroad. Photo: Erin Jonasson
Tax Commissioner Chris Jordan said some drug-makers had attempted to "back profits out" of Australia through a combination of transfer pricing and royalty payments to subsidiaries abroad. Photo: Erin Jonasson

Multinational drug companies are presenting a united front ahead of their appearance at the Senate's corporate tax avoidance inquiry, insisting they are honest, ethical and pay their fair share of tax.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Orange news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.